CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Sorafenib treatment of patients with intermediate and advanced hepatocellular carcinoma-institutional experience
DOI 10.1055/s-0029-1224045
Bibliografische Angaben
Nachweis in CareLit
Autor:innenH Németh, Á Petrányi, K Tamas, M Farkas, J Babics, G Bodoky
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Hepatocellular carcinoma is the third leading cause of cancer related death globally with gradually growing incidence. In more than 80% of the cases it develops in cirrhotic liver. During the course of the treatment we have to take in account the stage of the underlying liver disease. In 60–70% of the patients hepatocellular carcinoma is diagnosed at intermediate or advanced stage, when the prognosis o…
Zitieren
Zitierempfehlung
H Németh, Á Petrányi, K Tamas, M Farkas, J Babics, G Bodoky (2009) Sorafenib treatment of patients with intermediate and advanced hepatocellular carcinoma-institutional experience. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0029-1224045
Mit CareLit weiterarbeiten